Ayah Y. Almasri

Impact of CYP2C9 and VKORC1 Polymorphisms on Warfarin Sensitivity and Responsiveness in Jordanian Cardiovascular Patients during the Initiation Therapy

Laith N. AL‐Eitan, Ayah Y. Almasri, Rame Khasawneh · Genes · 2018 · 43 citations · Full text

Medicine, Genetics, Pharmacology +15

Effects of CYP2C9 and VKORC1 polymorphisms on warfarin sensitivity and responsiveness during the stabilization phase of therapy

Laith N. AL‐Eitan, Ayah Y. Almasri, Rame Khasawneh · Saudi Pharmaceutical Journal · 2019 · 40 citations · Full text

Medicine, Genetics, Pharmacology +16

Influence of <i>CYP4F2</i>, <i>ApoE</i>, and <i>CYP2A6</i> gene polymorphisms on the variability of Warfarin dosage requirements and susceptibility to cardiovascular disease in Jordan

Laith N. AL‐Eitan, Ayah Y. Almasri, Adan H. Alnaamneh et al. · International Journal of Medical Sciences · 2021 · 19 citations · Full text

Life Sciences, Genetics, Pharmacology +8

The Impact of Potassium Channel Gene Polymorphisms on Antiepileptic Drug Responsiveness in Arab Patients with Epilepsy

Laith N. AL‐Eitan, Islam M. Al-Dalalah, Afrah K. Elshammari et al. · Journal of Personalized Medicine · 2018 · 17 citations · Full text

Medicine, Genetics, Neurology +17

Effects of coagulation factor VII polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients during the initiation and maintenance phases of warfarin therapy

Laith N. AL‐Eitan, Ayah Y. Almasri, Sahar Al-Habahbeh · Pharmacogenomics and Personalized Medicine · 2019 · 15 citations · Full text

Medicine, Genetics, Pharmacology +15